Nektar Therapeutics
NKTR
#4605
Rank
NZ$3.52 B
Marketcap
NZ$125.85
Share price
-2.50%
Change (1 day)
454.77%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$13.62

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$13.71. In 2024 the company made an earnings per share (EPS) of NZ-$15.24 an increase over its 2023 EPS that were of NZ-$37.66.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$13.62-10.62%
2024NZ-$15.24-59.54%
2023NZ-$37.66-25.89%
2022NZ-$50.82-31.12%
2021NZ-$73.7814.86%
2020NZ-$64.23-1.19%
2019NZ-$65.01-163.96%
2018NZ$101.64-725.4%
2017NZ-$16.25-42.73%
2016NZ-$28.3883.33%
2015NZ-$15.4839.53%
2014NZ-$11.09-69.29%
2013NZ-$36.12-6.67%
2012NZ-$38.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.15-239.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.34-117.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.64-279.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$1.14-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.57-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.20-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.56-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland